A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Public ClinicalTrials.gov record NCT06470048. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Parallel Group, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety and Tolerability of Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate efficacy, safety and tolerability of s.c. ianalumab administered in participants with diffuse cutaneous systemic sclerosis relative to placebo
Study identification
- NCT ID
- NCT06470048
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 201 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 9, 2024 (Actual)
- Primary completion
- Jul 30, 2027 (Estimated)
- Completion
- Jul 31, 2034 (Estimated)
- Last update posted
- Oct 13, 2026
2024 – 2034
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Arthritis and Rheumatology Research PLLC | Mesa | Arizona | 85202 | — |
| UCLA | Los Angeles | California | 90095 | — |
| Hoag Hospital | Newport Beach | California | 92663 | — |
| Clinical Res Of W Florida | Clearwater | Florida | 33765 | — |
| GNP Research | Cooper City | Florida | 33024 | — |
| IRIS Research and Development | Plantation | Florida | 33324 | — |
| Sarasota Arthritis Res Ctr | Sarasota | Florida | 34239 | — |
| University of Chicago Hospitals | Chicago | Illinois | 60637 | — |
| Uni Of Michigan Health System | Ann Arbor | Michigan | 48109 | — |
| Hospital for Special Surgery | New York | New York | 10021 | — |
| West Tennessee Research Institute | Jackson | Tennessee | 38305 | — |
| Novel Research LLC | Bellaire | Texas | 77401 | — |
| Arthritis and Rheumatology Ins | Frisco | Texas | 75035 | — |
| Prolato Clinical Research Center | Houston | Texas | 77054 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 92 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06470048, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06470048 live on ClinicalTrials.gov.